134 related articles for article (PubMed ID: 38207385)
1. Tea and Coffee as the Cause of Sick-Headache.
West J Med Surg; 1840 Oct; 2(4):320-321. PubMed ID: 38207385
[No Abstract] [Full Text] [Related]
2. Association of tea and coffee consumption with the risk of all-cause and cause-specific mortality among individuals with metabolic syndrome: a prospective cohort study.
Wu E; Bao YY; Wei GF; Wang W; Xu HQ; Chen JY; Xu YN; Han D; Tao L; Ni JT
Diabetol Metab Syndr; 2023 Nov; 15(1):241. PubMed ID: 37993869
[TBL] [Abstract][Full Text] [Related]
3. Consumption of coffee and tea with all-cause and cause-specific mortality: a prospective cohort study.
Chen Y; Zhang Y; Zhang M; Yang H; Wang Y
BMC Med; 2022 Nov; 20(1):449. PubMed ID: 36397104
[TBL] [Abstract][Full Text] [Related]
4. Association of Coffee, Tea, and Caffeine Consumption With All-Cause Risk and Specific Mortality for Cardiovascular Disease Patients.
Zheng H; Lin F; Xin N; Yang L; Zhu P
Front Nutr; 2022; 9():842856. PubMed ID: 35811963
[TBL] [Abstract][Full Text] [Related]
5. Beverage habits and mortality in Chinese adults.
Odegaard AO; Koh WP; Yuan JM; Pereira MA
J Nutr; 2015 Mar; 145(3):595-604. PubMed ID: 25733477
[TBL] [Abstract][Full Text] [Related]
6. Green Tea and Coffee Consumption and All-Cause Mortality Among Persons With and Without Stroke or Myocardial Infarction.
Teramoto M; Muraki I; Yamagishi K; Tamakoshi A; Iso H
Stroke; 2021 Mar; 52(3):957-965. PubMed ID: 33535784
[TBL] [Abstract][Full Text] [Related]
7. Additive effects of green tea and coffee on all-cause mortality in patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry.
Komorita Y; Iwase M; Fujii H; Ohkuma T; Ide H; Jodai-Kitamura T; Yoshinari M; Oku Y; Higashi T; Nakamura U; Kitazono T
BMJ Open Diabetes Res Care; 2020 Oct; 8(1):. PubMed ID: 33087342
[TBL] [Abstract][Full Text] [Related]
8. Coffee and tea on cardiovascular disease (CVD) prevention.
Chieng D; Kistler PM
Trends Cardiovasc Med; 2022 Oct; 32(7):399-405. PubMed ID: 34384881
[TBL] [Abstract][Full Text] [Related]
9. The propensity of different brands of tea and coffee to cause staining associated with chlorhexidine.
Leard A; Addy M
J Clin Periodontol; 1997 Feb; 24(2):115-8. PubMed ID: 9062858
[TBL] [Abstract][Full Text] [Related]
10. Use of sugar in coffee and tea and long-term risk of mortality in older adult Danish men: 32 years of follow-up from a prospective cohort study.
Treskes RW; Clausen J; Marott JL; Jensen GB; Holtermann A; Gyntelberg F; Jensen MT
PLoS One; 2023; 18(10):e0292882. PubMed ID: 37851689
[TBL] [Abstract][Full Text] [Related]
11. Association of alcohol types, coffee and tea intake with mortality: prospective cohort study of UK Biobank participants.
Schaefer SM; Kaiser A; Behrendt I; Eichner G; Fasshauer M
Br J Nutr; 2023 Jan; 129(1):115-125. PubMed ID: 35109963
[TBL] [Abstract][Full Text] [Related]
12. Post-diagnostic coffee and tea consumption and breast cancer survival.
Farvid MS; Spence ND; Rosner BA; Willett WC; Eliassen AH; Holmes MD
Br J Cancer; 2021 May; 124(11):1873-1881. PubMed ID: 33762714
[TBL] [Abstract][Full Text] [Related]
13. Coffee or Tea? A prospective cohort study on the associations of coffee and tea intake with overall and cause-specific mortality in men versus women.
van den Brandt PA
Eur J Epidemiol; 2018 Feb; 33(2):183-200. PubMed ID: 29380105
[TBL] [Abstract][Full Text] [Related]
14. Coffee and tea consumption are inversely associated with mortality in a multiethnic urban population.
Gardener H; Rundek T; Wright CB; Elkind MS; Sacco RL
J Nutr; 2013 Aug; 143(8):1299-308. PubMed ID: 23784068
[TBL] [Abstract][Full Text] [Related]
15. Presence of anthraquinone in coffee and tea samples. An improved methodology based on mass spectrometry and a pilot monitoring programme.
Díaz-Galiano FJ; Murcia-Morales M; Gómez-Ramos MDM; Ferrer C; Fernández-Alba AR
Anal Methods; 2021 Jan; 13(1):99-109. PubMed ID: 33305763
[TBL] [Abstract][Full Text] [Related]
16. Association between coffee or tea consumption and cardiovascular outcomes in patients with stable coronary artery disease: Analysis from the CLARIFY registry.
Abtan J; Ducrocq G; Elbez Y; Ferrari R; Ford I; Fox KM; Tardif JC; Tendera M; Danchin N; Parkhomenko A; Reid CM; Gabriel Steg P
Arch Cardiovasc Dis; 2023; 116(8-9):382-389. PubMed ID: 37524628
[TBL] [Abstract][Full Text] [Related]
17. Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality.
Woodward M; Tunstall-Pedoe H
J Epidemiol Community Health; 1999 Aug; 53(8):481-7. PubMed ID: 10562866
[TBL] [Abstract][Full Text] [Related]
18. Effects of lifestyle and genetic polymorphisms on consumption of coffee or black tea and urinary caffeine levels.
Yang Toshihiro Kawamoto Takahiko Kat Oh Koji Mastuno M
Biomarkers; 1998; 3(4-5):367-77. PubMed ID: 23899363
[TBL] [Abstract][Full Text] [Related]
19. Effect of decaffeination of coffee or tea on gastro-oesophageal reflux.
Wendl B; Pfeiffer A; Pehl C; Schmidt T; Kaess H
Aliment Pharmacol Ther; 1994 Jun; 8(3):283-7. PubMed ID: 7918922
[TBL] [Abstract][Full Text] [Related]
20. Coffee or tea: Anti-inflammatory properties in the context of atherosclerotic cardiovascular disease prevention.
Surma S; Sahebkar A; Banach M
Pharmacol Res; 2023 Jan; 187():106596. PubMed ID: 36473629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
